stata se 11 2 Search Results


cp000521 112  (ATCC)
99
ATCC cp000521 112
Cp000521 112, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/10__2147_slash_idr__s202803-106-158-157?v=ATCC
Average 99 stars, based on 1 article reviews
cp000521 112 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
11 2 statistical software  (STATA Corporation)
99
STATA Corporation 11 2 statistical software
11 2 Statistical Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/pmc03942088-114-11-10?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
11 2 statistical software - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
phq 9 scores  (STATA Corporation)
99
STATA Corporation phq 9 scores
Phq 9 Scores, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/pm27965374-98-22-25?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
phq 9 scores - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
ve cadherin tyr731  (Novus Biologicals)
90
Novus Biologicals ve cadherin tyr731
(A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD <t>tyr731</t> ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , <t>VE</t> <t>CAD</t> tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.
Ve Cadherin Tyr731, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/pmc06305393-80-119-122?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
ve cadherin tyr731 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
data management software foxpro version 6.0  (FOXPRO Inc)
90
FOXPRO Inc data management software foxpro version 6.0
(A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD <t>tyr731</t> ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , <t>VE</t> <t>CAD</t> tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.
Data Management Software Foxpro Version 6.0, supplied by FOXPRO Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/pm27717859-24-5-12?v=FOXPRO+Inc
Average 90 stars, based on 1 article reviews
data management software foxpro version 6.0 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
stata statistical software  (STATA Corporation)
99
STATA Corporation stata statistical software
(A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD <t>tyr731</t> ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , <t>VE</t> <t>CAD</t> tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.
Stata Statistical Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/10__1158_slash_1078___0432__ccr___18___3358-110-22-22?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
stata statistical software - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
se version 13 0 software  (STATA Corporation)
99
STATA Corporation se version 13 0 software
(A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD <t>tyr731</t> ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , <t>VE</t> <t>CAD</t> tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.
Se Version 13 0 Software, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/pm27717859-24-22-21?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
se version 13 0 software - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
112 uv detector  (Gilson Inc)
90
Gilson Inc 112 uv detector
(A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD <t>tyr731</t> ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , <t>VE</t> <t>CAD</t> tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.
112 Uv Detector, supplied by Gilson Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/10__1021_slash_bc800050x-61-27-26?v=Gilson+Inc
Average 90 stars, based on 1 article reviews
112 uv detector - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
se 14  (STATA Corporation)
99
STATA Corporation se 14
(A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD <t>tyr731</t> ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , <t>VE</t> <t>CAD</t> tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.
Se 14, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/pmc05339045-196-6-5?v=STATA+Corporation
Average 99 stars, based on 1 article reviews
se 14 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
xh182 mdwj01 112  (ATCC)
90
ATCC xh182 mdwj01 112
(A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD <t>tyr731</t> ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , <t>VE</t> <t>CAD</t> tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.
Xh182 Mdwj01 112, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/10__2147_slash_idr__s202803-106-97-82?v=ATCC
Average 90 stars, based on 1 article reviews
xh182 mdwj01 112 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
modified il-2 bnt151  (BioNTech)
90
BioNTech modified il-2 bnt151
List of all conducted clinical trials for mRNA-based treatment of cancers (Until Jan 2024).
Modified Il 2 Bnt151, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/pmc10937594-115-7-31?v=BioNTech
Average 90 stars, based on 1 article reviews
modified il-2 bnt151 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
sas version 9.4  (SAS institute)
90
SAS institute sas version 9.4
List of all conducted clinical trials for mRNA-based treatment of cancers (Until Jan 2024).
Sas Version 9.4, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+se+11+2/pm34039500-81-190-189?v=SAS+institute
Average 90 stars, based on 1 article reviews
sas version 9.4 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


(A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD tyr731 ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , VE CAD tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.

Journal: Frontiers in Physiology

Article Title: The Endothelial Mechanotransduction Protein Platelet Endothelial Cell Adhesion Molecule-1 Is Influenced by Aging and Exercise Training in Human Skeletal Muscle

doi: 10.3389/fphys.2018.01807

Figure Lengend Snippet: (A–D) Changes in relative phosphorylation of eNOS and mechanosensor proteins from rest to passive leg movement conducted before and after the training period. Relative changes in (A) endothelial nitric oxide synthase serine 1177 phosphorylation (eNOS p117 ), (B) vascular endothelial growth factor receptor 2 serine 1177 (VEGF-R2 ser1177 ), (C) vascular endothelial cadherin tyrosine 731 (VE CAD tyr731 ), and (D) platelet endothelial adhesion molecule 1 tyrosine 713 (PECAM-1 tyr713 ) from young and old subjects before and after the training intervention. $ denotes a significant change from rest to passive leg movement, ∗ denotes difference from before training within group. Data are mean ± SD. (E) Representative western blots of mechanosensor proteins. Western blots from one young and one old subject, before and after training of VEGF-R2 ser1177 , VE CAD tyr731 and PECAM-1 tyr713 . Samples are run in dublicats and presented together with loading control glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Note that changes in eNOS phosphorylation are obtained from immunohistochemical staining of individual microvessels within cross sections of muscle biopsies while the mechanosensor proteins reflect changes in whole muscle homogenates. Please see the Materials and Methods section and Figure for representative images.

Article Snippet: After gel electrophoresis, the proteins were transferred (semidry) to a polyvinylidene difluoride membrane (Immobilon Transfer Membrane, Millipore), which was incubated with ∼10 ml of primary antibody over-night and then washed three times for 5 min in Tris-buffered saline-Tween before incubation with secondary antibody for 1 h. The membranes were incubated with the following primary antibodies: VEGF-R2 (sc-19530; Santa Cruz Biotechnology, Santa Cruz, CA, United States); VEGF-R2 Tyr1175 (2478, Cell Signaling Technology, Danvers, MA, United States); eNOS (BD 610287, BD Biosciences, San Jose, CA, United States; eNOS ser1177 (Calbiochem 482737, Merck Milipore, Darmstadt, Germany); PECAM-1 (AF806, R&D Systems Inc., Minneapolis, MN, United States); PECAM-1 Tyr713 (BS4666, Bioworld Technology, St. Louis Park, MN, United States); VE-cadherin (ab33168, Abcam, Cambridge, United Kingdom); VE-cadherin Tyr731 (NBP1-51393, Novus Biologicals, Littleton, CO, United States).

Techniques: Phospho-proteomics, Western Blot, Control, Immunohistochemical staining, Staining

List of all conducted clinical trials for mRNA-based treatment of cancers (Until Jan 2024).

Journal: Heliyon

Article Title: The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases

doi: 10.1016/j.heliyon.2024.e26971

Figure Lengend Snippet: List of all conducted clinical trials for mRNA-based treatment of cancers (Until Jan 2024).

Article Snippet: 112 , NCT04455620 , Encodes a modified IL-2 (BNT151) , In vivo , Solid Tumors , Monotherapy Combination with Anti-cancer Agents , Phase I/II (2021) , 84 , Adults (≥18) , BioNTech SE , United States Spain United Kingdom , Recruiting.

Techniques: Clinical Proteomics, In Vivo, Ex Vivo, Immunopeptidomics, Adjuvant, Isolation, Membrane, Mutagenesis, Transplantation Assay, Derivative Assay, Comparison, Vaccines, Knock-Out, Modification